Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the site's version history.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision: v3.4.2 is now displayed and the previous government funding lapse notice (v3.4.1) has been removed.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status; updated to Revision: v3.4.1 (removing Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a Show glossary UI option and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the Revision: v3.4.0 note; these are minor textual and interface changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4. No changes to study content, eligibility criteria, outcomes, or locations are indicated.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.